Alliance for Pandemic Preparedness

August 28, 2020

Self-Diagnosed COVID-19 in People with Multiple Sclerosis: A Community-Based Cohort of the UK MS Register

Category:

Topic:

Keywords (Tags):

  • A prospective observational cohort study found that people with multiple sclerosis (MS) and those taking immunomodulatory disease-modifying therapies were not at elevated risk of COVID-19. Among people with MS, 237 of 3,910 (6%) participants reported self-diagnosed COVID-19, which was a similar risk to among their siblings without MS (OR: 1.2, 95%CI: 0.9-1.6). Participants taking disease-modifying therapies were less likely to have self-diagnosed COVID-19 (OR=0.64, 95% CI: 0.43-0.96).

Evangelou et al. (Aug 27, 2020). Self-Diagnosed COVID-19 in People with Multiple Sclerosis: A Community-Based Cohort of the UK MS Register. Journal of Neurology, Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2020-324449